Avantik Appoints Jeffrey Waldman Chief

Avantik announced a leadership change on August 10, 2026. Avantik appointed healthcare executive Jeffrey Waldman as CEO, succeeding the retiring Mark Zacur, to lead the diagnostic lab solutions provider’s next phase of growth.

What changed

Jeffrey Waldman was named Chief Executive Officer. Waldman succeeds Mark Zacur, who is retiring and will continue as an advisor through year-end to help ensure a seamless transition.

Leader: Jeffrey Waldman
Role: Chief Executive Officer
Effective: Not specified in the announcement
Announcement date: August 10, 2026

Leadership background

Waldman has more than two decades of healthcare leadership experience, including a 19-year career at Henry Schein, where he served as president of the company’s global orthopedic business. Most recently, he was chairman and chief executive officer of National HME.

The mandate

Avantik said Waldman will lead the next phase of the company’s growth. Chairman Scott Garrett said Waldman was chosen to build on Avantik’s foundation and advance its momentum.

Why this matters for GTM teams

Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.

Source and methodology

This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.

Primary source: Avantik leadership announcement.